A commonly-prescribed multiple sclerosis (MS) infusion medication linked to a rare but serious side effect is safer to use when dosing intervals are extended, according to a new study led by MS specialists NYU Langone Health.
MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.